The way forward for Ketamine and Temper Disorders In 2019, the FDA and European Fee accepted the use of an esketamine nasal spready under the manufacturer name Spravato to treat depression. However, as of 2021, ketamine hasn't been permitted because of the FDA to deal with depression or other mental well being disorders, and for that reason, the me